The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123113086 12311308 6 F 20160822 20160427 20160901 EXP CN-TAKEDA-2016MPI003299 TAKEDA LU C, MIAO S. BORTEZOMIB IN THE TREATMENT OF 1 CASE OF SENILE REFRACTORY MANTLE CELL LYMPHOMA AND LITERATURE REVIEW. YI YAO QIAN YAN. 2014;24:192 74.00 YR F Y 0.00000 20160901 OT CN CN

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123113086 12311308 1 PS VELCADE BORTEZOMIB 1 Unknown 1.3 MG/M2, UNK U 21602 1.3 MG/M**2 INJECTION
123113086 12311308 2 SS VELCADE BORTEZOMIB 1 Unknown UNK U 21602 INJECTION
123113086 12311308 3 SS PREDNISOLONE. PREDNISOLONE 1 Unknown UNK U 0
123113086 12311308 4 SS DEXAMETHASONE. DEXAMETHASONE 1 Unknown 20 MG, UNK U 0 20 MG
123113086 12311308 5 SS DEXAMETHASONE. DEXAMETHASONE 1 Unknown UNK U 0
123113086 12311308 6 SS DOXORUBICIN HYDROCHLORIDE. DOXORUBICIN HYDROCHLORIDE 1 Intravenous (not otherwise specified) 30 MG, UNK U UNKNOWN 0 30 MG INJECTION
123113086 12311308 7 SS DOXORUBICIN HYDROCHLORIDE. DOXORUBICIN HYDROCHLORIDE 1 Intravenous (not otherwise specified) UNK U 0 INJECTION
123113086 12311308 8 SS DOXORUBICIN HYDROCHLORIDE. DOXORUBICIN HYDROCHLORIDE 1 Intravenous (not otherwise specified) UNK U 0 INJECTION
123113086 12311308 9 SS VINCRISTINE VINCRISTINE 1 Unknown UNK U 0
123113086 12311308 10 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown 300 MG, UNK U 0 300 MG
123113086 12311308 11 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown UNK U 0
123113086 12311308 12 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown UNK U 0
123113086 12311308 13 SS MABTHERA RITUXIMAB 1 Unknown UNK U 0
123113086 12311308 14 SS METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Unknown UNK U 0
123113086 12311308 15 SS VINDESINE VINDESINE 1 Unknown 3 MG, UNK U 0 3 MG
123113086 12311308 16 SS VINDESINE VINDESINE 1 Unknown UNK U 0
123113086 12311308 17 SS BENDAMUSTINE BENDAMUSTINE 1 Unknown UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123113086 12311308 1 Mantle cell lymphoma stage IV
123113086 12311308 3 Mantle cell lymphoma stage IV
123113086 12311308 4 Mantle cell lymphoma stage IV
123113086 12311308 6 Mantle cell lymphoma stage IV
123113086 12311308 9 Mantle cell lymphoma stage IV
123113086 12311308 10 Mantle cell lymphoma stage IV
123113086 12311308 13 Mantle cell lymphoma stage IV
123113086 12311308 14 Mantle cell lymphoma stage IV
123113086 12311308 15 Mantle cell lymphoma stage IV
123113086 12311308 17 Mantle cell lymphoma stage IV

Outcome of event

Event ID CASEID OUTC COD
123113086 12311308 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123113086 12311308 Bone marrow failure
123113086 12311308 Drug ineffective

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123113086 12311308 1 201310 0
123113086 12311308 4 201310 0
123113086 12311308 6 201310 0
123113086 12311308 10 201310 0
123113086 12311308 15 201310 0